Fasting oxyntomodulin, glicentin, and gastric inhibitory polypeptide levels are associated with activation of reward‐ and attention‐related brain centres in response to visual food cues in adults with obesity: A cross‐sectional functional MRI study
Open Access
- 8 January 2021
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 23 (5) , 1202-1207
Abstract
Postprandial increases in gastrointestinal hormones are associated with reduced energy intake, partially through direct effects on the brain. However, it remains unknown whether the fasting levels of gastrointestinal hormones are associated with altered brain activity in response to visual food stimuli. We therefore performed a whole‐brain regression cross‐sectional analysis to assess the association between fasting brain activations according to functional magnetic resonance imaging, performed during viewing of highly desirable versus less desirable food images, with fasting levels of five gastrointestinal hormones (glucagon‐like peptide [GLP]‐1, GLP‐2, oxyntomodulin, glicentin and gastric inhibitory polypeptide [GIP]) in 36 subjects with obesity. We observed that fasting blood levels of GIP were inversely associated with the activation of attention‐related areas (visual cortices of the occipital lobe, parietal lobe) and of oxyntomodulin and glicentin with reward‐related areas (insula, putamen, caudate for both, and additionally orbitofrontal cortex for glicentin) and the hypothalamus when viewing highly desirable as compared to less desirable food images. Future studies are needed to confirm whether fasting levels of oxyntomodulin, glicentin and GIP are associated with the activation of brain areas involved in appetite regulation and with energy intake in people with obesity.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (389891681 (PE 2431/3‐1:1))
This publication has 19 references indexed in Scilit:
- Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disordersExpert Opinion on Therapeutic Targets, 2018
- Obese individuals with type 2 diabetes demonstrate decreased activation of the salience‐related insula and increased activation of the emotion/salience‐related amygdala to visual food cues compared to non‐obese individuals with diabetes: A preliminary studyDiabetes, Obesity and Metabolism, 2018
- Obese individuals with more components of the metabolic syndrome and/or prediabetes demonstrate decreased activation of reward-related brain centers in response to food cues in both the fed and fasting states: a preliminary fMRI studyInternational Journal of Obesity, 2016
- Lorcaserin Administration Decreases Activation of Brain Centers in Response to Food Cues and These Emotion- and Salience-Related Changes Correlate With Weight Loss Effects: A 4-Week-Long Randomized, Placebo-Controlled, Double-Blind Clinical TrialDiabetes, 2016
- Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover studyMetabolism, 2016
- Central nervous system regulation of eating: Insights from human brain imagingMetabolism, 2016
- GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trialDiabetologia, 2016
- Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy ExpenditureThe Journal of Clinical Endocrinology & Metabolism, 2015
- GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in HumansDiabetes, 2014
- International Union of Pharmacology. XXXV. The Glucagon Receptor FamilyPharmacological Reviews, 2003